CN Patent

CN105992591A — 用于降低抗原特异性免疫原性的组合物和方法

Assigned to Research Foundation of the State University of New York · Expires 2016-10-05 · 10y expired

What this patent protects

提供了用于诱导针对包括治疗性抗原类的抗原类的免疫耐受性的方法。该方法包括向个体给药以单一制剂形式或作为分开的制剂的OPLS或其它脂质组合物和抗原，其中将分开的制剂同时或相继给药。

USPTO Abstract

提供了用于诱导针对包括治疗性抗原类的抗原类的免疫耐受性的方法。该方法包括向个体给药以单一制剂形式或作为分开的制剂的OPLS或其它脂质组合物和抗原，其中将分开的制剂同时或相继给药。

Drugs covered by this patent

Patent Metadata

Patent number
CN105992591A
Jurisdiction
CN
Classification
—
Expires
2016-10-05
Drug substance claim
No
Drug product claim
No
Assignee
Research Foundation of the State University of New York
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.